What Are Clinical Trials?

Clinical trials are research studies that test new medical treatments, drugs, or procedures on human volunteers. For mesothelioma patients, clinical trials represent an opportunity to access innovative therapies that may be more effective than current standard treatments.

Every treatment that has become standard care—from chemotherapy combinations to immunotherapy—went through clinical trials first. By participating, patients not only potentially benefit themselves but also contribute to medical knowledge that helps future patients.

Types of Mesothelioma Clinical Trials

Treatment Trials

These test new treatments or combinations of treatments, including:

New chemotherapy drugs or combinations
Immunotherapy agents like checkpoint inhibitors
Targeted therapies that attack specific cancer cell features
Novel surgical techniques or intraoperative treatments
Gene therapy approaches

Prevention and Screening Trials

These studies focus on:

Better ways to detect mesothelioma early
Biomarkers that predict disease progression
Methods to prevent mesothelioma in high-risk populations

Quality of Life Trials

These explore ways to improve comfort and daily life for patients, including:

Pain management strategies
Nutritional support
Psychological interventions
Palliative care approaches

Phases of Clinical Trials

Understanding trial phases helps set realistic expectations about what to expect at each stage:

Phase	Purpose	Participants
Phase I	Test safety and determine safe dosage	15-30 patients
Phase II	Evaluate effectiveness and side effects	25-100 patients
Phase III	Compare new treatment to standard care	100-1,000+ patients
Phase IV	Monitor long-term effects after FDA approval	Large population

Promising Clinical Trial Areas

Immunotherapy Combinations

Building on the success of drugs like pembrolizumab (Keytruda) and nivolumab (Opdivo), current trials are testing:

Dual immunotherapy combinations (anti-PD-1 + anti-CTLA-4)
Immunotherapy + chemotherapy combinations
Personalized cancer vaccines
CAR-T cell therapy for mesothelioma

Emerging approaches like epigenetic therapy are also being explored to enhance immune responses against mesothelioma cells.

Targeted Therapy

Research targeting specific genetic mutations and cellular pathways:

Anti-angiogenic drugs that block tumor blood supply
BAP1 and other genetic mutation targeted therapies
PARP inhibitors for DNA repair-deficient tumors

Advanced diagnostic tools like molecular testing and proteomics research help identify which targeted therapies may be most effective for your specific cancer profile.

Novel Drug Delivery

Innovative ways to get treatment directly to tumors:

HIPEC variations with different chemotherapy combinations
Intrapleural immunotherapy delivery
Pressurized intraperitoneal aerosol chemotherapy (PIPAC)

How to Find Clinical Trials

1. ClinicalTrials.gov

The U.S. National Library of Medicine maintains a comprehensive database at ClinicalTrials.gov. Search using terms like "mesothelioma" and filter by location, phase, and status.

2. Cancer Center Resources

Major cancer centers often have dedicated clinical trial navigators who can help match you with appropriate studies. Contact the research office at cancer centers near you.

3. Patient Advocacy Organizations

Organizations like the Mesothelioma Applied Research Foundation maintain lists of current trials and can help connect you with researchers.

4. Your Oncology Team

Your oncologist may know about trials specifically suited to your situation. Don't hesitate to ask about clinical trial options at every appointment.

Questions to Ask About Clinical Trials

What is the purpose of this study?
What treatments will I receive?
What are the possible risks and side effects?
How might this trial affect my daily life?
Will I need to travel frequently?
Who will pay for treatment and travel costs?
Can I leave the trial if I want to?

Eligibility Criteria

Each trial has specific inclusion and exclusion criteria to ensure patient safety and meaningful results. Common factors include:

Mesothelioma type and stage: Many trials focus on specific cell types or disease stages
Previous treatments: Some trials require no prior treatment; others seek patients who've progressed after standard therapy
Overall health status: Measured by performance status scores
Organ function: Liver, kidney, and heart function tests
Age and other medical conditions

Benefits and Risks

Potential Benefits

Access to cutting-edge treatments
Close monitoring by medical team
Contributing to medical research
Potential for better outcomes
Free or reduced-cost treatment

Potential Risks

Unknown side effects
Treatment may not work
More frequent medical visits
May receive placebo (in some trials)
Insurance coverage questions

Informed Consent

Before joining any clinical trial, you must provide informed consent. This process ensures you understand:

The purpose of the study
What will happen during the trial
Potential risks and benefits
Your rights as a participant
That participation is voluntary

Important: You can withdraw from a clinical trial at any time for any reason.

Costs and Insurance

Understanding trial costs is important:

Research costs (experimental treatment, extra tests) are usually covered by the trial sponsor
Standard care costs may be covered by insurance
Travel and accommodation may be reimbursed in some cases

Always discuss financial aspects with the trial coordinator and your insurance provider before enrolling.

Featured Clinical Trials (2026)

Note: Trial availability changes frequently. Always verify current status through official channels. For the latest trials launching this year, see our guide to 2026 clinical trials.

Nivolumab + Ipilimumab Combination Trials

Ongoing Phase II/III studies testing dual immunotherapy for pleural mesothelioma after promising early results. Multiple locations nationwide.

Tumor-Treating Fields + Chemotherapy

Studies combining Optune Lua device with standard chemotherapy for pleural mesothelioma.

CAR-T Cell Therapy Trials

Early-phase studies of engineered immune cells targeting mesothelioma-specific antigens.

Making the Decision

Deciding whether to participate in a clinical trial is deeply personal. Consider:

Your current treatment options and prognosis
The specific trial's potential benefits and risks
Impact on your quality of life
Your personal values and goals
Input from your family and medical team

Remember: Clinical trials are not a last resort. Many patients benefit most when enrolled early in their treatment journey.

👨‍⚕️

Medically Reviewed

Dr. Emily Carter, MD

Board-Certified Medical Oncologist specializing in thoracic cancers

Last reviewed: March 2026

Why Clinical Trials Matter for Mesothelioma

Clinical trials are particularly important for mesothelioma because the disease is rare and treatment options have historically been limited. Every approved treatment for mesothelioma—from the pemetrexed-cisplatin chemotherapy regimen to the nivolumab-ipilimumab immunotherapy combination—was developed and validated through clinical trials. For some patients, especially those whose cancer has progressed after standard therapies, clinical trials may offer access to promising new treatments that are not yet available outside the research setting.

Participating in a clinical trial does not mean receiving experimental or unproven therapy instead of standard care. Most trials compare new treatments against the current standard of care, meaning participants in the control group receive the best established treatment. Trials also provide patients with close monitoring, frequent imaging, and regular assessments by specialized research teams, which can benefit the overall quality of care received.

Types of Clinical Trials

Clinical trials progress through phases, each designed to answer different questions. Phase 1 trials test new treatments in a small number of patients to determine safe dosage levels and identify side effects. These trials are often open to patients who have exhausted standard options. Phase 2 trials enroll more patients and evaluate whether the treatment is effective against a specific cancer. Phase 3 trials compare the new treatment directly against the current standard of care in large patient populations; positive phase 3 results are typically required for FDA approval.

Current mesothelioma trials span a wide range of approaches. Immunotherapy trials are exploring new combinations of checkpoint inhibitors, novel immune targets, and ways to overcome immune resistance in mesothelioma. Targeted therapy trials test drugs directed at specific genetic mutations or molecular pathways altered in mesothelioma cells, such as BAP1 loss, Hippo pathway dysregulation, and EZH2 overexpression. Cell-based therapies, including CAR T-cell approaches and dendritic cell vaccines, represent newer frontiers in mesothelioma research.

How to Find and Enroll in a Clinical Trial

Finding an appropriate clinical trial begins with a conversation with your oncologist, who can evaluate whether your diagnosis, treatment history, and overall health meet the eligibility criteria for specific studies. ClinicalTrials.gov, maintained by the National Institutes of Health, is the most comprehensive database of clinical trials in the United States and internationally. The National Cancer Institute's Cancer Information Service (1-800-4-CANCER) can help identify trials relevant to your diagnosis.

Eligibility for clinical trials depends on factors including mesothelioma type and stage, prior treatments received, current health status, organ function (measured through blood tests), and specific molecular characteristics of the tumor. Some trials require fresh tumor tissue or blood samples for biomarker testing as part of the screening process. Distance from the trial site is a practical consideration, though some trials include provisions for travel assistance or have multiple enrollment locations across the country.

Patient Protections in Clinical Trials

All clinical trials in the United States are overseen by institutional review boards (IRBs) that review the study design, monitor patient safety, and ensure informed consent. Before enrolling, you will receive a detailed informed consent document explaining the trial's purpose, procedures, potential risks and benefits, and your right to withdraw at any time without affecting your standard medical care. Clinical trial participation is always voluntary, and leaving a trial does not prevent you from receiving other treatments.

Mesothelioma Clinical Trials: Accessing Tomorrow's Treatments Today